NTC to assess RMG safety measuresThe National Tripartite Committee on building and fire safety in RMG factories decided to form a technical sub-committee to assess the structural integrity and safety measures of all active ready-made garment (RMG) factories. The decision was ... The New Nation, 1 week ago |
4 images for safety monitoring committee | ||||
DMC Recommends ImmunoCellular Therapeutics To Continue ICT-107 Phase II TrialImmunoCellular Therapeutics, Ltd. (IMUC: Quote) announced that the Data Monitoring Committee or DMC has completed a pre-specified interim analysis of the ICT-107 phase II clinical trial in patients with newly diagnosed glioblastoma and recommended ... RTTNews.com, 1 week ago
ImmunoCellular (IMUC) Receives Support from DMC to Continue ICT-107 Phase III
Street Insider, 1 week ago
|
Intercargo Calls for Improved Reporting Following Ship CasualtiesDuring the forthcoming IMO Maritime Safety Committee (MSC 92 to be held June 12-21, 2013) Intercargo, the International Association of Dry Cargo Shipowners will present its Bulk Carrier Casualty Report and will call for member States to fully ... Marine Link, 1 week ago
Intercargo Calls for Improved and Transparent Public Reporting Following Ship Casualties
All About Shipping, 1 week ago
International Perspectives on Solutions to Internal Displacement
Brookings Institution, 1 week ago
The Internet and Our Freedoms Are in Danger
Bright Side of News, 1 week ago
|
ImmunoCellular Therapeutics (NYSE MKT: IMUC) Continues ICT-107 P2TrialRecommendation of Data Monitoring Committee following Interim Analysis IMUC's Data Monitoring Committee (DMC) has completed a pre-specified interim analysis of the ICT-107 P2 clinical trial in patients with newly diagnosed glioblastoma ... Proactive Investors USA, 1 week ago
ImmunoCellular Therapeutics Announces Recommendation of Data Monitoring Committee to Continue ICT-107 Phase II Trial Following Interim Analysis
Oncology Business Review, 1 week ago
IMMUNOCELLULAR THERAPEUTICS LTD: ImmunoCellular Therapeutics Announces Recommendation of Data Monitoring Committee to Continue ICT-107 Phase II Trial Following Interim Analysis
4 Traders, 1 week ago
|
Sanofi says ORIGIN results on Lantus cardiovascular safety integrated into EU product labelSanofi announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for inclusion in the Lantus (insulin glargine) product label of safety and efficacy data from the ... PharmaBiz, 1 week ago
ORIGIN Results on LantusĀ® Cardiovascular Safet...
MoneyAM, 2 weeks ago
Sanofi Updates Lantus Label in EU
Pharma Live, 2 weeks ago
|
Corporate report: Defence Environment and Safety Committee (DESC) Assurance ReportsUpdated: Title of page has been changed The Defence Environment and Safety Board (DESB) was superseded by the Defence Environment and Safety Committee (DESC) as of 12th January 2012. The Defence Environment and Safety Committee (DESC) is ... Cabinet Office, 2 weeks ago
Nigerian oil industry impacts on health, safety and environment
SHEQ Africa, 6 days ago
SA health and safety law update; 3 June
SHEQ Africa, 2 weeks ago
|
Building firms under SM scannerSHARJAH: Sharjah City Municipality (SM) will form a committee of experts to inspect and monitor the activities of around 15,000 construction companies and more than 400 consulting firms registered in Sharjah, which has the largest number of ... The Gulf Today, 6 days ago
|
Monitoring Abuses by White House Office, Clean Air Director/ Senior Attorney, Washington, D.C. This week, the Senate Committee on Homeland Security and Governmental Affairs is holding a confirmation hearing on one of the most important White House positions youve never heard of. ... NRDC Worldview, 1 week ago
|
Ruling party, govt. push for tougher penalties on unsafe foodMeeting with the agriculture, fisheries, and food safety ministers Wednesday, the ruling party's policy committee agreed to push for a stiff fine on producers of illegal food products. If caught at least twice manufacturing unsanitary or ... Arirang, 2 weeks ago
|
Alert and On GuardOver the past decade, a series of adverse drug safety-related events have led to increased scrutiny and drug safety monitoring regulations. In response to events such as Merck's withdrawal of Vioxx from the market on September 30, 2004, Pfizer's ... PharmaAsia, 2 weeks ago
|